
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 8.040 | 8.040 | 0.000 |
Shares | 92.960 | 92.960 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.591 | 26.300 |
Price to Book | 3.881 | 3.288 |
Price to Sales | 5.215 | 4.479 |
Price to Cash Flow | 17.060 | 20.099 |
Dividend Yield | 1.902 | 2.136 |
5 Years Earnings Growth | 8.003 | 8.150 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 97.640 | 96.666 |
Consumer Defensive | 2.360 | 2.828 |
Number of long holdings: 36
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shanghai Allist Pharmaceuticals Co | CNE100005XJ7 | 9.67 | 105.37 | -0.41% | |
Suzhou Zelgen Biopharma | CNE100003RP1 | 9.05 | 102.83 | +0.13% | |
InventisBio | CNE100005Q22 | 8.77 | 28.91 | +4.18% | |
BeOne Medicines | CNE100005XT6 | 7.66 | 279.12 | -2.30% | |
WuXi AppTec | CNE1000031K4 | 7.64 | 99.15 | -1.89% | |
Jiangsu Hengrui | CNE0000014W7 | 5.64 | 66.24 | -0.90% | |
Kelun Pharm A | CNE100000PW7 | 5.55 | 35.04 | +0.46% | |
Sinopep Allsino Bio Pharmaceutical Co | CNE1000051X5 | 5.21 | 36.70 | 0.00% | |
APT Medical | CNE100004C45 | 3.55 | 311.28 | +1.04% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 3.30 | 227.68 | -1.41% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CIFM China Emerging Power Class H | 5.8B | 81.16 | 16.44 | - | ||
CIFM China Emerging Power Class A | 5.8B | 81.27 | 16.48 | 16.25 | ||
China Intl AsiaPacific Advantage St | 2.51B | 22.13 | 14.99 | 7.98 | ||
CIFM Technology Qian Yan Alloc | 2.45B | 52.82 | 12.52 | 11.79 | ||
China International China Advanced | 1.67B | 78.97 | 16.36 | 12.13 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review